EMPA-KIDNEY study results infographic
This medical educational webinar is intended for healthcare professionals only
to communicate clinical trial updates in the EMPOWER program, including the EMPA-KIDNEY trial.
Empagliflozin is currently not indicated for the treatment of chronic kidney disease. Please
refer to the local product information for the current indication in your country.
SC-SG-01342
%product_id%